Earlier in the year, the skincare company ARCTIVA shared that it has developed a revolutionary new formulation of over-the-counter and steroid-free skincare products that could be greatly beneficial for the dermatological conditions of Eczema and Psoriasis.
This new product lineup by ARCTIVA combines its proprietary glycolipid technology HYDROSURF with natural ingredients, including FDA-approved ingredients such as salicylic acid and colloidal oatmeal to bring a steroid-free and medicated skincare solutions to people suffering from psoriasis and eczema.
Access a comprehensive market research report on the Global Dermatological Therapeutics Market consisting of the emerging trends, key players, product launches, market share, market size, FDA approvals and much more.
The Psoriasis Cream comes with the active ingredient of 1% salicylic acid the Eczema Cream comes with the active ingredient of 2% colloidal oatmeal. Both creams also contain essential oils, vitamins, and other biological and cruelty-free ingredients such as botanicals. Besides these ingredients, both creams use ARCTIVA’s proprietary glycolipid technology, which is claimed to be the number one factor for the effectiveness of the cream.
This glycolipid technology developed by ARCTIVA is known as HYDROSURF and is exclusively present in their products. The technology helps boost moisturization by increasing the absorption rates of the skin, helps in exfoliation and also reduces inflammation.
Both creams have shown great effectiveness in independent consumer studies carried out by ARCTIVA, with the Eczema cream showing improvements in more than 90% of the patients within 28 days, and the Psoriasis cream showing effectiveness in 92% of the patients within 60 days.
Moreover, the studies showcased that the benefits and improvements kept becoming better the longer the creams were used. Because of this high effectiveness and improvements, ARCTIVA has even attached a 60-day money-back guarantee to both creams.
Both the ARCTIVA Psoriasis Cream and ARCTIVA Eczema Cream are available to buy throughout the United States, wherein more than 40 million people suffer from these skin conditions yearly. These creams are guaranteed to provide relief and solutions to many people suffering from these skin conditions.
It is likely that ARCTIVA will continue to provide further effective skincare solutions – with a cream for Rosacea also listed as ‘coming soon’ on their website. It will be interesting to see how their existing and upcoming products and developments impact the global dermatological therapeutics market, and how they will impact and benefit the wide number of people suffering from various skincare issues.